SoniVie Ltd

medical devices

About

SoniVie Ltd is a medical device company focused on developing innovative ultrasound-based therapeutic technologies for treating hypertension and related cardiovascular and pulmonary conditions. Founded in 2014 and headquartered in Israel, with operations in the US and Europe, SoniVie specializes in its proprietary Therapeutic Intra-Vascular Ultrasound (TIVUS™) system. This system targets nerves surrounding blood vessels to perform renal denervation and other therapies aimed at reducing blood pressure. The TIVUS™ system is the only ultrasound denervation platform actively being developed for three therapeutic areas: pulmonary artery denervation for pulmonary hypertension, renal artery denervation for resistant hypertension, and lung denervation for chronic obstructive pulmonary disease (COPD). The technology is currently investigational and undergoing clinical trials, including a pivotal trial with the FDA. SoniVie has received multiple FDA Breakthrough Device Designations, reflecting its innovative approach. The company recently completed a $60 million Series C financing round to support its clinical and regulatory efforts. In 2025, SoniVie is set to be acquired by Boston Scientific Corporation, enhancing its presence in the cardiovascular device market.

Technologies

Outlook WordPress.org Google Font API Nginx Google Tag Manager Mobile Friendly Remote AI Circle

Keywords

medical equipment manufacturing clinical investigation clinical trials fda ide approval medical device industry b2b blood vessel nerves pulmonary hypertension therapy investigational medical device sympathetic nerve disruption blood vessel nerve treatment medical devices medical device development minimally invasive therapy blood pressure reduction catheter-based therapy medical technology innovation ultrasound for nerve ablation chronic obstructive pulmonary disease fda regulatory process renal denervation renal nerve ablation medical equipment and supplies manufacturing ultrasound catheter technology hypertensive disorder treatment investigational device fda breakthrough device healthcare equipment & supplies ultrasound nerve disruption pulmonary hypertension

Location

22 שבזי, Rosh Haayin, Center District, Israel, 4802122

Related Companies

Companies in the same industry